24Nov/21
Ushering in a “Raging” Era—Fiercely Competitive Phase III ADCs (part I)
An antibody-drug conjugate (ADC) is composed of an antibody, a chemical linker, and a small molecular payload, and takes advantage of the specific targeting binding ability of antibody to transport cytotoxic payloadRead More…